Study title:
J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8.
Iodixanol: risk of subsequent contrast nephropathy in cancer patients with
underlying renal insufficiency undergoing diagnostic computed tomography
examinations.
Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH.
J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8.
Iodixanol: risk of subsequent contrast nephropathy in cancer patients with
underlying renal insufficiency undergoing diagnostic computed tomography
examinations.
Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area:
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: IODINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|